Sanofi and Abbott Collaborate to Assimilate Glucose Sensing and Insulin Delivery Technologies to Manage Diabetes
Shots:
- Abbott and Sanofi team up to develop tools integrating their blood sugar tracking and insulin delivery technologies to help diabetes patients in managing their conditions
- The non-exclusive agreement will combine Abbott’s FreeStyle Libre continuous glucose monitoring system with Sanofi’s connected insulin pens- apps and cloud software currently in development- allowing patients & doctors to share data and to make better treatment decisions around medication- nutrition and lifestyle
- Abbott's FreeStyle Libre system is used to monitor the glucose level via sensor and is linked with an app that enables users to capture real-time glucose levels- their eight-hour glucose history- and how their glucose is currently changing on their smartphones
Click here to read full press release/ article
| Ref: Abbott | Image: Abbott
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com